Epidemiology (HCV)
"Prevalence of Hepatitis C in Patients with Hemorrhagic Diseases in Saxonia-Anhalt (Germany)."
Published in Hepatitis Weekly, August 19th, 1996
According to an abstract submitted by the authors to the 22nd International Congress of the World Federation of Hemophilia, held June 23-28, 1996, in Dublin, Ireland, "Of all virus infections transmitted by blood and blood components Hepatitis C is especially important due to its chronicity and high risk of subsequent liver cirrhosis and of developing malignoma. Until 1989 our patients were treated almost exclusively with unpooled, not virus-inactivated blood preparations. Due to the special epidemiologic situation (in East Germany) all our patients are HIV negative. None of the patients receiving virus-inactivated plasma preparations developed hepatitis. They will be excluded...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-08-19)
More Articles from Hepatitis Weekly
- Therapy (HCV)
IFN-(alpha) Treatment Diminishes Th2 Response in HCV Disease - Epidemiology (HBV)
TAG Mutant Appears to Prevail in Taiwanese HBV Patients - Pathogenesis (HBV)
Cellular Model May Clarify HBV Latency - Testing (HCV)
Rapid HCV RNA Detection Method Outlined - Virology (HBV)
Amino Acid Substitutions Occur in HBV Core Region - Virology (HCV)
Absence of Genetic Heterogeneity of HCV Studied - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
